Increasing throughput of parallel on-line extraction liquid chromatography/electrospray ionization tandem mass spectrometry system for GLP quantitative bioanalysis in drug development
- PMID: 14755613
- DOI: 10.1002/rcm.1327
Increasing throughput of parallel on-line extraction liquid chromatography/electrospray ionization tandem mass spectrometry system for GLP quantitative bioanalysis in drug development
Abstract
An approach is described with turbulent flow on-line extraction liquid chromatography/electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) for GLP quantitative bioanalysis of a drug candidate. Two systems were built in-house with standard laboratory parts and equipments. One system consisted of one gradient HPLC pump, one isocratic pump, one ten-port valve, two turbulent flow columns, one analytical column, one autosampler and one mass spectrometer. Using this system, an injection-to-injection cycle time of 0.8 min was achieved. By adding an additional valve, another analytical column and an isocratic pump, the injection-to-injection cycle time decreased to 0.4 min. Validation results from the two systems showed that precision and accuracy were acceptable for GLP quantitative analyses. The system was utilized to support sample bioanalysis of a drug candidate in a first-time in-human clinical trial.
Copyright 2004 John Wiley & Sons, Ltd.
Similar articles
-
Ternary-column system for high-throughput direct-injection bioanalysis by liquid chromatography/tandem mass spectrometry.Rapid Commun Mass Spectrom. 2000;14(2):105-11. doi: 10.1002/(SICI)1097-0231(20000130)14:2<105::AID-RCM842>3.0.CO;2-Q. Rapid Commun Mass Spectrom. 2000. PMID: 10623938
-
Utility of porous graphitic carbon stationary phase in quantitative liquid chromatography/tandem mass spectrometry bioanalysis: quantitation of diastereomers in plasma.Rapid Commun Mass Spectrom. 2006;20(12):1831-7. doi: 10.1002/rcm.2517. Rapid Commun Mass Spectrom. 2006. PMID: 16705646
-
Increased throughput in quantitative bioanalysis using parallel-column liquid chromatography with mass spectrometric detection.Rapid Commun Mass Spectrom. 2001;15(12):994-9. doi: 10.1002/rcm.330. Rapid Commun Mass Spectrom. 2001. PMID: 11400209
-
Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry.Clin Biochem. 2005 Apr;38(4):328-34. doi: 10.1016/j.clinbiochem.2004.11.007. Clin Biochem. 2005. PMID: 15766734 Review.
-
Turbulent flow bioanalysis in drug metabolism and pharmacokinetics.Bioanalysis. 2011 Jul;3(14):1663-71. doi: 10.4155/bio.11.137. Bioanalysis. 2011. PMID: 21756098 Review.
Cited by
-
Effects of food on the relative bioavailability of lapatinib in cancer patients.J Clin Oncol. 2009 Mar 10;27(8):1191-6. doi: 10.1200/JCO.2008.18.3285. Epub 2009 Feb 2. J Clin Oncol. 2009. PMID: 19188677 Free PMC article. Clinical Trial.
-
A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer.Mol Cancer Ther. 2016 Sep;15(9):2251-8. doi: 10.1158/1535-7163.MCT-15-0908. Epub 2016 Jun 20. Mol Cancer Ther. 2016. PMID: 27325685 Free PMC article. Clinical Trial.
-
Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumours.Invest New Drugs. 2014 Jun;32(3):481-8. doi: 10.1007/s10637-013-0055-4. Epub 2013 Dec 19. Invest New Drugs. 2014. PMID: 24346280 Clinical Trial.
-
Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528.Cancer Chemother Pharmacol. 2013 Nov;72(5):1089-96. doi: 10.1007/s00280-013-2297-4. Epub 2013 Sep 22. Cancer Chemother Pharmacol. 2013. PMID: 24057042 Free PMC article. Clinical Trial.
-
Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.Sci Transl Med. 2010 Jan 27;2(16):16ra7. doi: 10.1126/scitranslmed.3000389. Sci Transl Med. 2010. PMID: 20371474 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical